DELL'ERA, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 9.554
NA - Nord America 6.781
AS - Asia 5.690
SA - Sud America 780
AF - Africa 128
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 12
Totale 23.021
Nazione #
US - Stati Uniti d'America 6.501
GB - Regno Unito 3.867
CN - Cina 2.411
SG - Singapore 1.326
IT - Italia 1.299
DE - Germania 932
SE - Svezia 714
BR - Brasile 562
RU - Federazione Russa 552
HK - Hong Kong 521
IN - India 390
FR - Francia 349
TR - Turchia 349
NL - Olanda 342
ES - Italia 307
UA - Ucraina 258
IE - Irlanda 230
KR - Corea 199
CA - Canada 193
FI - Finlandia 164
PL - Polonia 116
EU - Europa 111
VN - Vietnam 105
DK - Danimarca 98
JP - Giappone 93
CO - Colombia 88
ID - Indonesia 76
AU - Australia 68
BE - Belgio 67
MX - Messico 55
GR - Grecia 44
RO - Romania 42
CH - Svizzera 41
AR - Argentina 40
CI - Costa d'Avorio 38
PT - Portogallo 38
BD - Bangladesh 30
AT - Austria 26
CL - Cile 24
UZ - Uzbekistan 21
EG - Egitto 18
IL - Israele 18
TW - Taiwan 18
EC - Ecuador 17
SA - Arabia Saudita 17
TH - Thailandia 15
DZ - Algeria 14
HU - Ungheria 14
PK - Pakistan 14
VE - Venezuela 14
PE - Perù 13
TN - Tunisia 13
UY - Uruguay 11
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 10
IQ - Iraq 9
JO - Giordania 9
RS - Serbia 9
CZ - Repubblica Ceca 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
IR - Iran 7
MY - Malesia 7
KZ - Kazakistan 6
MA - Marocco 6
PA - Panama 6
PH - Filippine 6
SK - Slovacchia (Repubblica Slovacca) 6
NI - Nicaragua 5
NO - Norvegia 5
BG - Bulgaria 4
CR - Costa Rica 4
HR - Croazia 4
LT - Lituania 4
NP - Nepal 4
PS - Palestinian Territory 4
QA - Qatar 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
GT - Guatemala 3
JM - Giamaica 3
KE - Kenya 3
LK - Sri Lanka 3
MK - Macedonia 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
IM - Isola di Man 2
OM - Oman 2
SN - Senegal 2
TZ - Tanzania 2
A1 - Anonimo 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
Totale 23.092
Città #
Southend 3.556
Singapore 768
Chandler 661
Ashburn 577
Hong Kong 462
Beijing 411
Milan 401
Dallas 381
Seattle 305
Princeton 275
Wilmington 251
Dublin 228
Ann Arbor 207
Council Bluffs 196
Dearborn 168
Boardman 164
Los Angeles 158
Nanjing 150
Fairfield 145
Jacksonville 144
Redwood City 144
Bengaluru 125
Hefei 125
Redmond 123
Santa Clara 123
Woodbridge 109
Des Moines 105
Warsaw 104
Guangzhou 100
Shanghai 99
Toronto 91
Sakarya 87
Houston 83
New York 81
Buffalo 79
Phoenix 73
Mountain View 72
Shenyang 72
Frankfurt am Main 71
Moscow 71
Jinan 65
Cambridge 63
São Paulo 61
Rome 60
Barcelona 59
Munich 55
Nanchang 54
Hangzhou 53
Andover 50
Tokyo 49
Serra 47
Cangzhou 46
Somerville 45
Bogotá 43
Düsseldorf 43
Brussels 42
Hebei 41
Jakarta 40
Zhengzhou 40
Changsha 38
Columbus 38
Roxbury 38
Abidjan 37
Helsinki 37
The Dalles 36
Tianjin 36
Fuzhou 33
Ho Chi Minh City 33
Wuhan 33
Rio de Janeiro 32
Nuremberg 31
San Diego 31
Hanover 30
Grafing 29
Jiaxing 29
Paris 29
Chicago 28
Ottawa 28
Berlin 27
Istanbul 27
Saint Petersburg 27
Bitonto 26
Madrid 26
Brooklyn 23
Fremont 21
Hanoi 21
Bühl 20
Mumbai 20
Sydney 20
London 19
Mannheim 19
Xian 19
Bologna 18
Chengdu 18
Hamburg 18
Santiago 18
Turku 18
Central District 17
Chennai 17
Hyderabad 17
Totale 13.583
Nome #
Preemptive-TIPS improves outcome in high-risk variceal bleeding : An observational study 1.879
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis 800
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results 430
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension 403
Partecipazione al gruppo di studio europeo sui disordini vascolari del fegato (European Network for the Vascular Disorders of the Liver, EN-Vie). Pubblicazione di due articoli in qualità di collaboratore: 1. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL; EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, Management and Outcome of the Budd-Chiari syndrome. Ann Int Med 2009; 151(3):167-75; 2. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D; European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51(1):210-8. 338
Endoscopy in acute variceal bleeding: Not always the sooner, the better? 321
Schwann cell hamartoma: case report 294
High-D-Dimer plasma levels predict poor outcome in esophageal variceal bleeding 255
Splanchnic Hemodynamics and Intestinal Vascularity in Crohn's Disease: An In Vivo Evaluation Using Doppler and Contrast-Enhanced Ultrasound and Biochemical Parameters 249
Mortality from Acute Upper Gastrointestinal Bleeding (UGIB): The Role of the Organizational and Health Care Course: A Prospective Multicentre Observational Study in Italy 249
Noninvasive testing in the management of children with suspected inflammatory bowel disease 246
Medical treatment of portal hypertension 221
Acute variceal bleeding : pharmacological treatment and primary/secondary prophylaxis 220
Risk factors for thrombophilia in extrahepatic portal vein obstruction 219
Poor outcome from acute upper gastrointestinal bleeding in patients with liver cirrhosis: a prospective multicenter observational study 211
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method 208
Laparoscopic Heller Myotomy and Dor Fundoplication for the Treatment of Esophageal Achalasia After Sleeve Gastrectomy-a Video Vignette 203
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis 198
High levels of factor VIII and risk of extra-hepatic portal vein obstruction 195
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 194
Diagnosis and treatment of portal hypertension 192
Role of JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis 191
Local circulation of VEGF is involved in collateral vessels development in cirrhotic patients with portal hypertension 188
The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy 186
Fibrinolytic and hemostatic abnormalities in gastroesophageal variceal bleeding in cirrhotic patients 184
Efficiency of current guidelines for primary prevention of variceal bleeding in cirrhosis 180
Portal vein thrombosis in liver cirrhosis: prevalence, epidemiological and clinical features 180
Optimal timing of endoscopy is associated with lower 42-daymortality in variceal bleeding 179
Influence of portal vein thrombosis (PVT) on the efficacy of variceal band ligation 178
Efficiency of current guidelines for primary prevention of variceal bleeding in cirrhosis 177
Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn's disease 177
Revisione Critica delle linee guida di Baveno VI 176
Trigger and target transfusion strategy in patients with non-variceal acute upper gastrointestinal bleeding (NV-AUGIB) : A prospective multicentre observational stud 175
Primary prophylaxis of variceal bleeding in cirrhotic patients : a cohort study 173
P.07.9 DIETARY HABITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE 173
Capsule endoscopy in portal hypertension 171
Prognostic value of a single hepatic venous pressure gradient measurement in cirrhotic patients 171
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 169
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) deficiency is an independent prognostic factor of death in variceal bleeding in cirrhosis of the liver 168
Emorragie digestive alte da varici: update 2008-2009 167
Consensus Baveno IV 165
Influence of portal vein thrombosis (PVT) on the efficacy of variceal band ligation 164
Risk factors for depression and anxiety in Crohn's disease 163
Accuracy of fecal calprotectin, bowel ultrasonography and inflammatory indexes in the diagnosis of paediatric inflammatory bowel disease 163
Gastropatia da ipertensione portale nei pazienti con cirrosi epatica 162
Efficiency of current guidelines for primary prevention of variceal bleeding in cirrhosis 162
Thrombin generation in patients with cirrhosis : the role of platelets 159
JAK2 V617F mutation in extra hepatic portal vein obstruction and budd-chiari syndrome 159
Fibrinolytic and hemostatic abnormalities in gastroesophageal variceal bleeding in cirrhotic patients 157
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 153
Bowel preparation in patients with inflammatory bowel disease 152
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS 152
The coagulopathy of cirrhosis assessed by thromboelastography and its correlation with conventional coagulation parameters 151
Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease 150
Medical management of variceal bleeding in patients with cirrhosis 149
Splanchnic haemodynamics and intestinal vascularity in ileal crohn's disease : an in vivo evaluation using doppler ultrasound, contrast-enhanced ultrasound and biochemical parameters 148
Novel developments in esophageal vascular disorders 147
Prognostic value of a single hepatic venous pressure gradient measurement in cirrhotic patients 146
JAK2 V617F mutation in extra hepatic portal vein obstruction and budd-chiari syndrome 146
Transfusion strategy and death risk in patients with acute non variceal upper gastro intestinal bleeding (nv-ugib) in italy : a prospective multicenter observational study 146
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 145
Ipertensione portale 143
High incidence of heparin-induced thrombocytopaenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH) 143
Prognostic value of a single hepatic venous pressure gradient measurement in cirrhotic patients 143
Correlations between hepatic vein portal gradient (HVPG) and complications of portal hypertension in cirrhosis of the liver 143
Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma : considerations on the efficacy of treatment with fresh-frozen plasma 143
Natural history of extra-hepatic portal vein obstruction (EHPVO) in Western countries 141
Does portal vein thrombosis impact on the efficacy of variceal band ligation 140
Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score 138
Confronto tra legatura elastica e sclerosi endoscopica nel trattamento delle varici esofagee 137
Baveno VII – Renewing consensus in portal hypertension 136
MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction 135
The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation 135
Intestinal gas and liver steatosis: a casual association? A prospective multicentre assessment 135
Diagnosis and monitoring of portal hypertension 134
MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction 134
Role, efficacy and safety of budesonide-MMX in ulcerative colitis in real life : a study in a third-level center 133
Vocal Tract Discomfort and Dysphonia in Patients Undergoing Empiric Therapeutic Trial with Proton Pump Inhibitor for Suspected Laryngopharyngeal Reflux 133
Review article : the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding 132
JAK2 V617F mutation in extra hepatic portal vein obstruction and budd-chiari syndrome 132
High incidence of heparin-induced thrombocytopaenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH) 130
Profilassi primaria con legatura delle varici in pazienti affetti da cirrosi epatica con controindicazioni, intolleranza o non responders alla terapia farmacologica con beta-bloccanti 129
Anti-TNF-ALFA second-line infliximab therapy in patients affected by Crohn’s disease and ulcerative colitis: who and how recovers remission? 129
Non-invasive diagnosis of cirrhosis and the natural history of its complications 127
Presence of esophageal varices in patients with a recent histological diagnosis of cirrhosis of the liver: evaluation of clinical predictors 127
Dietetic intervention and nutritional status in adult patients with Crohn's disease : preliminary results 127
Diagnosis and therapy of esophageal vascular disorders 126
Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when 125
Portal vein thrombosis in inflammatory bowel diseases : a single-center case series 125
Respiratory infection in patients with cirrhosis and acute varicealbleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients 125
HVPG and clinical/endoscopic features in liver cirrhosis: correlations and threshold values for complications of portal hypertension 124
Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey from the Italian society of endoscopic surgery and new technologies (SICE), the Italian society of digestive endoscopy (SIED), the world society of emergency surgery-Italy chapter (WSESit), and the Italian society of surgical endoscopy and digestive diseases (ISSE) 124
Reply 121
Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis 120
Risk factors of death in variceal bleeding: combined effect of thrombin activatable fibrinolysis inhibitor (TAFI) deficiency and Child-Pugh C class 120
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis 119
Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation 118
Tratamiento de la hemorragia aguda por varices esofagicas y gastricas 117
Approccio al paziente con emorragia gastrointestinale manifesta (superiore e inferiore) 116
Thrombin activatable fibrinolysis inhibitor (TAFI) deficiency is an independent prognostic factor of death in variceal bleeding in cirrhosis of the liver 116
Totale 19.202
Categoria #
all - tutte 62.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.479


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.716 0 0 0 0 222 212 162 157 217 170 412 164
2021/20222.019 166 91 108 149 145 109 130 176 221 225 128 371
2022/20232.456 268 275 210 296 257 442 72 131 253 54 124 74
2023/20241.574 66 108 94 85 303 177 105 111 57 99 191 178
2024/20254.071 190 422 89 436 302 128 201 424 240 414 310 915
2025/20262.927 743 632 716 605 231 0 0 0 0 0 0 0
Totale 24.098